JP2023548590A5 - - Google Patents
Info
- Publication number
- JP2023548590A5 JP2023548590A5 JP2023527276A JP2023527276A JP2023548590A5 JP 2023548590 A5 JP2023548590 A5 JP 2023548590A5 JP 2023527276 A JP2023527276 A JP 2023527276A JP 2023527276 A JP2023527276 A JP 2023527276A JP 2023548590 A5 JP2023548590 A5 JP 2023548590A5
- Authority
- JP
- Japan
- Prior art keywords
- targeting agent
- subject
- sclc
- composition according
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063110664P | 2020-11-06 | 2020-11-06 | |
| US63/110,664 | 2020-11-06 | ||
| PCT/US2021/058218 WO2022098979A1 (en) | 2020-11-06 | 2021-11-05 | Methods and systems for classification and treatment of small cell lung cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023548590A JP2023548590A (ja) | 2023-11-17 |
| JP2023548590A5 true JP2023548590A5 (enExample) | 2024-11-12 |
Family
ID=81457377
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023527276A Pending JP2023548590A (ja) | 2020-11-06 | 2021-11-05 | 小細胞肺がんの分類と治療のための方法およびシステム |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20230405117A1 (enExample) |
| EP (1) | EP4240755A4 (enExample) |
| JP (1) | JP2023548590A (enExample) |
| KR (1) | KR20230104233A (enExample) |
| CN (1) | CN116997572A (enExample) |
| AU (1) | AU2021372988A1 (enExample) |
| CA (1) | CA3200665A1 (enExample) |
| WO (1) | WO2022098979A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN121293357A (zh) | 2022-08-22 | 2026-01-09 | 雅博得乐医疗公司 | Dll3结合分子及其用途 |
| CN116466089B (zh) * | 2023-04-27 | 2025-10-31 | 杭州华得森生物技术有限公司 | 采用微流控芯片与多重免疫荧光探针技术的基于sclc分子分型的ctc的检测试剂盒及其鉴定方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5117765B2 (ja) * | 2007-05-28 | 2013-01-16 | 国立大学法人 東京大学 | 抗ｒｏｂｏ１抗体を含むｐｅｔ用腫瘍診断剤 |
| PL2530091T3 (pl) * | 2010-01-29 | 2018-08-31 | Chugai Seiyaku Kabushiki Kaisha | Przeciwciało przeciwko dll3 |
| CN104520324A (zh) * | 2012-02-24 | 2015-04-15 | 施特姆森特Rx股份有限公司 | Dll3调节剂及其使用方法 |
| MA41613A (fr) * | 2015-02-23 | 2018-01-02 | Abbvie Stemcentrx Llc | Récepteurs antigéniques chimériques anti-dll3 et procédés d'utilisation desdits récepteurs |
| TWI848953B (zh) * | 2018-06-09 | 2024-07-21 | 德商百靈佳殷格翰國際股份有限公司 | 針對癌症治療之多特異性結合蛋白 |
-
2021
- 2021-11-05 JP JP2023527276A patent/JP2023548590A/ja active Pending
- 2021-11-05 AU AU2021372988A patent/AU2021372988A1/en active Pending
- 2021-11-05 EP EP21890132.0A patent/EP4240755A4/en active Pending
- 2021-11-05 US US18/252,005 patent/US20230405117A1/en active Pending
- 2021-11-05 CA CA3200665A patent/CA3200665A1/en active Pending
- 2021-11-05 WO PCT/US2021/058218 patent/WO2022098979A1/en not_active Ceased
- 2021-11-05 CN CN202180088545.0A patent/CN116997572A/zh active Pending
- 2021-11-05 KR KR1020237018874A patent/KR20230104233A/ko active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021155431A5 (enExample) | ||
| JP2023540732A5 (enExample) | ||
| JP2019536430A5 (enExample) | ||
| JP2022502371A5 (enExample) | ||
| JP2019522490A5 (enExample) | ||
| CN107531790A (zh) | 一种能联合免疫细胞增强肿瘤杀伤能力的双特异性抗体及其制备方法和应用 | |
| JP2020525032A5 (enExample) | ||
| JP2020530285A5 (enExample) | ||
| JP2020193210A5 (enExample) | ||
| JP2021511811A5 (enExample) | ||
| JP2017526339A5 (enExample) | ||
| JP2021524270A5 (enExample) | ||
| JP2020516305A5 (enExample) | ||
| JP2010535713A5 (enExample) | ||
| JP2021524275A5 (enExample) | ||
| JP2020537520A5 (enExample) | ||
| JP2018526988A5 (enExample) | ||
| JP2010511388A5 (enExample) | ||
| JP2015517470A5 (enExample) | ||
| JP2017519501A5 (enExample) | ||
| JP2016520520A5 (enExample) | ||
| Ma et al. | Reforming solid tumor treatment: the emerging potential of smaller format antibody-drug conjugate | |
| JP2017521054A5 (enExample) | ||
| JP2021510697A5 (enExample) | ||
| JP2021167329A5 (enExample) |